New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy

The Urologic Clinics of North America
W G Nelson, J W Simons

Abstract

Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism-based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J KuerbitzM B Kastan
Nov 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G R HudesR Comis
Jan 1, 1990·The Prostate·H B Carter, D S Coffey
Oct 1, 1990·The Journal of Urology·D J LightnerL Moore
Jun 1, 1991·The Journal of Urology·R A MortonP C Walsh
Jan 1, 1991·British Medical Bulletin·I J Fidler
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoP H Wiernik
Apr 1, 1990·Trends in Genetics : TIG·L M Matrisian
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Feb 8, 1990·The New England Journal of Medicine·C G MoertelJ H Glick
Mar 1, 1990·The American Journal of Surgical Pathology·J E McNealT A Stamey
Jun 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A EisenbergerM A Friedman
Jan 23, 1987·Science·J Folkman, M Klagsbrun
Jan 1, 1987·Nouvelle Revue Française D'hématologie·A Camez, G Tobelem
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Mar 1, 1989·The Journal of Urology·R P GibbonsR M Weissman
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A W PartinD S Coffey
Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A E ChangS M Steinberg
Jun 1, 1988·The Journal of Urology·E V Kramolowsky
Apr 1, 1982·Urology·R deVere WhiteC A Olsson
Mar 1, 1983·Urology·R deVere WhiteC A Olsson
Oct 22, 1993·Cell·D M HockenberyS J Korsmeyer
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K J PientaL E Flaherty

❮ Previous
Next ❯

Citations

Feb 1, 2003·Urology·Endre Z Neulander, Mark S Soloway

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.